In medtech, iRhythm Technologies plans to expand its heart monitoring technology to detect other diseases like sleep apnea. The CDC's advisory board criticized public health cuts amid various global health challenges. Lithuanian startup Atrandi Biosciences raised $25 million to advance its cell analysis technology. Other notable updates include the reversal of plans to end free Covid-19 test shipments, a record remission from CAR-T therapy, and Johnson & Johnson's potential sale of its stroke care business. AI-generated voice clones are aiding communication for patients with motor neuron diseases.
Key takeaways:
- Recursion's Altitude Lab is launching a pre-seed venture fund to support biotech startups amid policy shifts and funding uncertainties.
- The Trump Administration is shifting its avian flu strategy towards containment and vaccination, with a conditional license granted for a poultry flu vaccine.
- The FDA has approved GSK's new vaccine against invasive meningococcal disease, targeting all five major types of bacteria causing the disease.
- Nvidia unveiled Evo 2, an AI model for life sciences, trained on DNA from over 100,000 species, available on its BioNeMo platform.